ABSTRACT BACKGROUND: There is limited data about ICU, short and long-term mortality prediction of severe CAP with neutrophil-to-lymphocyte ratio (NLR): N-terminal proB-type natriuretic peptide (NT-proBNP): C-reactive protein (CRP). AIM: Besides the known severity indexes of ICU, can NLR, NT-proBNP, CRP predict ICU, short and long term mortality? METHODS: A retrospective cohort study was carried out in a level III ICU of a tertiary training hospital for chest diseases and thoracic surgery. RESULTS: Over the study period, a total of 143 patients were enrolled in the study. The APACHE II scoring showed a signifi cantly higher predicting performance for ICU mortality (p = 0.002). The performance for predicting short term mortality NLR (p = 0.039) and long term mortality NTproBNP (p = 0.002) had a signifi cantly higher performance. The survival analysis revealed that mortality was signifi cantly higher in patients with CURB65 score ≥ 4 (p = 0.047). CONCLUSION: NLR, NTproBNP > 2000pg/mL can be used to predict pneumonia severity in ICU alike CURB65 and PSI. Higher NLR, APACHE II and atrial fi brillation can cause an important mortality factor in long term. Consequently, clinicians should take an attention for good cardiac evaluation and cardiac follow-up of patients with CAP (Tab. 4, Fig. 3, Ref. 36). Text in PDF www.elis.sk.
Introduction
Pneumonia poses a risk for respiratory failure (ARF) (1, 2) . Community acquired pneumonia (CAP): when requiring an intensive care unit (ICU): has an increased risk of mortality. In daily life, clinicians need predictors to gauge outcomes for these patients. Some biochemical parameters mediators [C-reactive-protein (CRP)] and pneumonia risk scores such as CURB-65 and pneumonia Severity Index (PSI)] are currently used to predict mortality (3) (4) (5) . There is limited data about ICU, short and long-term mortality prediction of severe CAP with neutrophil lymphocyte ratio (NLR): N-terminal proB-type natriuretic peptide (NT-proBNP): C-reactive protein (CRP) .
N-terminal proB-type natriuretic peptide (NT-proBNP) is released from cardiac ventricles in response to stress/stretch/hypoxia. However, it is also increased by noncardiac causes, such as sepsis, pulmonary embolism, pulmonary hypertension, cor pulmonale with chronic obstructive pulmonary disease (6) (7) (8) . Pneumonia with an acute respiratory failure (ARF) may similarly lead to an increase in NT-proBNP secretion. Studies are ongoing in an attempt to identify biochemical markers that can be used for clinical and prognostic assessment of pneumonia (9) (10) (11) . NT-proBNP may offer potential advantages over clinical scores and biomarkers, as it is reliable and easy to measure (12) . Recent studies mention NLR as a new infl ammatory marker in exacerbation of chronic obstructive pulmonary diseases and in prognosis of lung cancer, colorectal cancer and acute coronary syndrome (13) (14) (15) (16) (17) .
In literature, there are only few studies published on ICUpatients with pneumonia regarding the primary outcome of longterm-mortality (10, 12, 18) .
The research question of this study is: can NLR, NT-proBNP and CRP predict ICU, short and long term mortality of patients with pneumonia?
Materials and methods
The study was designed as a retrospective cohort study in a level III ICU of a tertiary training hospital for chest diseases and thoracic surgery between January 2012 and May 2013. The study was approved by the local ethics committee of Kartal Lutfi Kirdar Teaching and Research Hospital and ethical approval was in accordance with the Declaration of Helsinki. Due to the retrospective nature of the study design, an informed consent was not obtained. The identities of the patients that were provided to be used, have been approved by the scientifi c committee of the hospital.
Patients
Pneumonia patients aged over 18 years, patients admitted to the ICU within 24 hours of hospital presentation and those with NT-proBNP measurements available were included in the study. Subject inclusion is summarized in a fl ow chart (Fig. 1.) 
Defi nition

Pneumonia
Pneumonia was defi ned as the presentation of the acute onset of symptoms suggestive of lower respiratory tract infection and radiographical evidence of a new infi ltrate (20, 21) .
ARF
"Hypoxic ARF" was defi ned, when partial arterial oxygen pressure in an inspired fractionated oxygen (PaO 2 /FiO 2 ) was < 300 and a partial arterial carbon dioxide pressure (PaCO 2 ) was < 45 mmHg. "Hypercapnic and hypoxemic ARF" was defi ned if PaCO 2 > 45 mmHg and PaO 2 /FiO 2 < 300 and "hypercapnic ARF" was defi ned if PaCO 2 > 45 mmHg and PaO 2 / FiO 2 > 300 (22, 23) . Severity of pneumonia Acute physiology and chronic health evaluation (APACHE II) scores were calculated for patients on admission to the ICU (22) . Pneumonia Severity Index (PSI) and CURB 65 score were calculated. Pneumonia Severity Index (PSI) is a scoring system to estimate the short term mortality risk for pneumonia patients and there are a total of 20 variables (3, 24) . CURB 65 is another scoring system for predicting pneumonia severity and has the following variables: confusion of new onset, blood urea nitrogen greater than 19 mg/dL, respiratory rate of 30 breaths per minute or greater, systolic blood pressure less than 90 mmHg or diastolic blood pressure 60 mmHg or less and the age 65 years or more (5).
Measurements
Complete blood count Total leukocyte, neutrophil, eosinophil, lymphocyte and platelet counts and MPV were determined using a Coulter LH 780 Haematology Analyser (Beckman Coulter, USA).
CRP
CRP was checked by the nephelometry method BN II System with a Siemens (Germany). The normal range of CRP is 0-5 mg/L.
NT-proBNP
Blood samples for NT-proBNP were collected at the time of the fi rst 24 hours in admission to ICU. Plasma was collected with the standard sampling tubes containing heparin-Na or EDTA. NTproBNP measurements were performed using PATHFAST assay based on chemiluminescent immunoassay (CLIA) and MIGRA-TION methodology.
Neutrophil-to-lymphocyte ratio
As a marker of systemic infl ammation, NLR was defi ned as absolute neutrophil count divided by absolute lymphocyte count.
Microbiology
Bronchial secret of patients were collected by a deep tracheal 64 (55) 49 (42) 44 (38) 27 (23) 25 (22) 18 (16) 11 (10) 46 (40) 22 (19) 10 (37) 13 (48) 9 (33) 10 (37) 9 (33) 5 (19) 4 (15) 5 ( aspiration if the patient was intubated and sputum was collected into a petri dish, when patients were non-intubated. In the case of a very low temperature (< 35 °C) or high fever (> 38 °C): a venous blood sample was collected into an aerobic culture media. Empirical antibiotic treatment was initiated following a clinical diagnosis and immediately after obtaining results of culture (21) .
Mechanical ventilation
The application of non-invasive mechanical ventilation (NIV) or invasive mechanical ventilation (IMV) in the ICU, the lengths of ICU stays (days): ICU mortality (mortality during the ICU stay) and mortality after discharge were recorded. NIV was the fi rst choice of ventilatory support for hypercapnic and hypoxemic respiratory failure (ABG analysis pH 7.28-7.34, PaCO 2 = 45-90 mmHg, PaO 2 /FiO 2 > 200 and a Glasgow coma scale > 13) if the patient was alert, able to protect the airway, had no risk of aspiration and no burn or wound on the face (25) . IMV was applied with ICU ventilators (Puritan Bennett 760, Newport and Vela): if the patient had criteria for intubation, such as cardiac arrest, increased work of breathing, respiratory depression, shock and altered mental status. The Richmond agitation sedation scale was used to assess the daily need for sedation (25) .
Data recording
Data of community acquired pneumonia (CAP) cases admitted to the intensive care unit with ARF and with NT-proBNP levels available were recorded from the patients' ICU fi les. The patients either required IMV or NIV were judged to be in an unstable condition requiring an intensive care.
Demographics, comorbidities including diabetes mellitus (DM): hypertension, COPD/asthma, congestive heart failure, coronary artery disease (CAD): malignancy and diffuse parenchymal lung disease, neurological diseases (Alzheimer's disease, cerebrovascular attack, Parkinson's disease ): use of long-term oxygen therapy (LTOT) and long-term mechanical ventilation (MV) (NIV or invasive [IMV]): body mass index (BMI) and length of ICU stay were also recorded.
Complete blood count, CRP, biochemistry, radiology patterns and antibiotic therapy data were also recorded. Arterial blood gas (ABG) values at the time of ICU admission were recorded from the patients' fi les.
Outcomes
The primary outcome was long term mortality (180 days after ICU admission): and the secondary outcome was short term mortality (30 days after ICU admission)
Statistical analysis
The Mann-Whitney U test and the Student's t test were used for analysis of continuous variables with non-parametric and parametric values, respectively. The chi square test was applied for categorical variables (gender, comorbidity) of survivors and non-survivors. The median with interquartile range (IQR) was employed for non-parametric continuous variables, and the mean ± standard deviation (SD) was used for parametric continuous variables. Count and percentage were used when applicable. The p value < 0.05 was accepted as statistically signifi cant. 30 and 80 days of survival analysis were done by the Kaplan Meier survival curve. ROC curve analysis was used for NT-proBNP, NLR, CRP, PSI score and APACHE score for mortality (ICU, short and long term).
Results
Totally, 143 patients were enrolled in the study. The mean age was 69 ± 12 years and 58 % of the patients were male. The baseline characteristics and comorbidities of pneumonia patients are summarized in the Table 1 . The comorbidities were similar in survivors and nonsurvivors, chronic obstructive lung diseases (COPD) and hypertension were the most frequent comorbidities. Table 2 shows the comparison of survivors and nonsurvivors of the intensive care unit. The nonsurvivors in ICU were more obese than survivors (p = 0.021). Hypertension was more common than the other comorbidities among nonsurvivors in ICU. Long term oxygen therapy use at home was signifi cantly higher in nonsurvivors.
The culture work up and microorganisms isolated from clinical culture specimens in ICU are summarized in the Table 3 . For 77 patients (54 %): diagnostic procedures such as bronchial lavage, bronchial lavage, blood, and urine cultures were performed to identify the microorganism causing sepsis. Agents were identifi ed by culture positivity and Acinetobacter Baumannii was the major pathogen isolated (n = 9.6 %).
Cox regression analyses is summarized in the Table 4 for short and long term mortality after ICU admission. We included atrial Table 4 .
The comparison between the performance of NTproBNP, APACHE II, PSI, CRP and NLR is shown in Figure 2 . The performance of APACHE II in predicting ICU mortality was significantly higher (p = 0.002). The performance of NLR (p = 0.039): predicting short term mortality and NTproBNP (p = 0.002) predicting long term mortality was signifi cantly higher. Figure 3 illustrates Kaplan -Meier survival functions. The survival analysis revealed that mortality was signifi cantly higher in patients with CURB65 score ≥ 4 (p = 0.047).
Discussion
In the recent study, we showed that NLR, NTproBNP > 2000 pg/mL could be used to asses pneumonia severity as well as CURB65 and PSI. And higher NLR and higher APACHE II score on admission to ICU had a higher risk of long term mortality (180 days).
Pneumonia severity scores are predictors of short term mortality and may help to decide on hospitalization (9, 11) . In reality, clinical practice scores are diffi cult to calculate and parameters in the scoring system may be missed. In the present study, the CURB-65 score was a predictor of short term mortality, whereas the PSI score showed no signifi cant difference in assessment of short-term mortality (3, (26) (27) (28) . This study supports the theory that higher NT-proBNP levels are associated with cardiac dysfunction leading to long term mortality (29) . Systemic infl ammation, endothelial dysfunction, hypoxia, catecholamine release and systemic vasodilatation cause an increased myocardial oxygen demand and decreased myocardial contraction resulting in increased cardiac mortality (8). Krüger et al described mid-regional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-atrial natriuretic peptide (CT-prANP) and CTproAVP as better predictors of 28-day and 180-day morality than CRB 65 scores (8) .
Acute coronary syndrome, arrhythmias, heart failure, and stroke are cardiovascular conditions reportedly associated with long-term mortality among CAP patients (30) (31) (32) (33) (34) (35) . In the present study, pneumonia patients with AF had a signifi cantly higher mortality. Interestingly, AF seems to be another prognostic factor for mortality. Patients with AF need to be followed closely, even after discharge from ICU. Infl ammation has also been reported as a risk factor for AF. Pneumonia can also have a negative effect on existing fi brillation by causing atrial fi brillation. The relationship of mortality and pneumonia associated with AF has not been reported. AF is also often observed in patients with COPD (32, 33) .
Infl ammation, hypoxia and electrolyte disturbance also play an important role in precipitating the onset of AF or increasing AF in malignancy and COPD (33) . Long term cardiovascular mortality risk seems to be an increased sequela from CAP, compared to the healthy population (34) (35) (36) . In the present study, malignancy was the most signifi cant and common comorbidity in both short and long term mortality and was predictably much higher in patients with long term mortality.
There are some limitations of the present study; as this is a retrospective study, all required data may not be available. The study was carried out in a single centre and as such there can be limited generalization of the data. In addition, the mean age of the study population was above 65 years, thus there was a low amount of information on the younger population. The small sample size limits the ability to detect small, but potentially signifi cant associations. The strength of this study lies in the data indicating the potential predictor for pneumonia severity of NLR and high NTproBNP levels in pneumonia in ICU.
Conclusion
Higher NT-proBNP values (above 2000 pg/mL) and NLR can be used to predict pneumonia severity in ICU as well as CURB65 and PSI. These promising results of routinely used total blood count test has helpful information for pneumonia severity diseases. Higher NLR and APACHE II score together with the presence of atrial fi brillation can be an important sequelae leading to long term mortality in CAP. The clinician should focus on a thorough cardiac evaluation and even cardiac follow-up of patients with CAP. The results of this pilot study are hypothesis-generating and provide the direction for future prospective studies.
